Click to Share
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Pharma Remove
Related Tags

July 2014
We Tu Mo Su Sa Fr Th
23 22 21 20 19 18 17

pharma Press Releases

  + XML/RSS  

By smi group
SMi's Antibody Drug Conjugate masterclass, taking place on the 2 December in London, will provide comprehensive insights into CMC issues during the development, with a particular focus on the assessment and control of the quality of such products.

By American Conference Institute
New York - Monday, November 25,2013 American Conference Institute (ACI) is pleased to introduce its Legal, Regulatory, & Compliance Forum on Controlled Substances, which will provide basic training in core regulatory concepts dealing with...

By NCTechNews
Enhanced Profiles to Include Company Q&A, Product and Services Spotlight, Discounted Advertising

By GMR Data Ltd
GMR Data forecast that the global cancer drugs market will reach $143.7bn by 2023. Brand new report published today.

By visiongain
LONDON, UK, 15th November 2013: A new report by visiongain calculates the global pharmaceutical anti-counterfeiting technologies market will reach $1.11bn in 2014 and its revenues will show strong growth to 2024.

By Ockham Development Group, Inc.
Develop your own 'Career GPS' to strengthen your career planning

By visiongain
London, UK, 8th November 2013: A new report by visiongain predicts that unit sales of pre-filled syringes will reach 3.5 billion in 2014. Growth is forecast for the global pre-filled syringe market throughout the period 2014-2024.

By BaseCase
Over the last several years pharma sales and marketing strategy has changed, moving towards HEOR-based engagement with payers and providers rather than traditional prescriber marketing.

By BaseCase
In the life sciences industries, the growth of the iPad has brought the promise of much more interactive and sophisticated value messaging.

By Visiongain
A new report by visiongain predicts the world smoking cessation drugs market will reach $2.5 billion in 2017. That forecast and others appear in Smoking Cessation Drugs: World Market Prospects 2013-2023, published in September 2013.

By Visiongain
A new report by visiongain lists three Chinese companies among the top 10 biosimilar drug manufacturers worldwide - the highest representation for any country. Those firms are 3SBio, Beijing SL Pharmaceutical and Shanghai Fosun Pharmaceutical.

By Shore Strategies Health
This alliance will provide the biotech, pharmaceutical and medical device community with capable consultative, advisors as well as strategic, seamless solutions.

By GeyerGorey LLP
Patricia Davis, a twenty-year veteran of the Department of Justice, has joined GeyerGorey LLP as of counsel. She previously served as Assistant Director, Fraud Section, Civil Division, U.S.

By visiongain
A new report by visiongain predicts that the global over-the-counter pharmaceuticals market will reach $106.3bn in 2017. This forecast and others appear in World OTC Pharmaceutical Market 2013-2023, published in October 2013.

By visiongain
A new report by visiongain predicts that the world market for vaccines will reach $48bn in 2015. From this market, vaccine contract manufacturing will reach $0.62bn in 2015.

By visiongain
A new report by visiongain forecasts the world market for pharma contract manufacturing will expand by 5% in 2013. Strong growth for market-leading contract manufacturing organisations (CMOs) will drive that sales growth.

By Visiongain
London, UK. 29th April 2013: Visiongain’s latest report examines the global mHealth market with a focus on service types, perceived benefits and the key drivers and barriers to uptake.

By Verilogue
Verilogue is bringing extensive knowledge of the interactions between patients and physicians to the Point of Care National conference, Nov. 6-7 in Philadelphia. Verilogue will be presenting "Bridging the Conversational Gaps at the Point of Care."

By Visiongain
A new report by visiongain predicts that world drug delivery technology market revenues will reach $198.4bn in 2017.

By visiongain
A new report by Visiongain predicts the market for asthma and COPD therapies will reach $41.23bn in 2017. That industry generated $34.15bn in 2012, and its revenues will show strong growth to 2023.

By Reportstack
2014 Opportunities in the Global Infectious Disease Testing Market is a new 7 country(France, Germany, Italy, Japan, Spain, UKUSA) strategic analysis of major business opportunities in the infectious disease testing market during the next five years

By Metrics Inc.
Company now has more CPIP professionals on staff than any other contract pharma organization

By Reportstack
Reportstack has added a new market report on 2014 Opportunities in the Global Blood Banking Market which is a is a new seven-country strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants...

By American Conference Institute
American Conference Institute (ACI) is pleased to announce that The Honorable Edward R. Korman, U.S.D.J., from United States District Court for the Eastern District of New York who issued the landmark decision in Tummino v.

By SFL Regulatory Affairs & Scientific Communication
SFL's Managing Director to speak at Swiss event on pharma and medtech collaborations.

By Pharma IQ
New report highlights the contradiction at the heart of the pharmaceutical industry in 2013!

By Global Media Strategies
Premier Life Sciences Event to Feature Industry Leaders in Therapeutics, Agriculture, Bioinformatics, Drug and Device Discovery, Enabling Technologies, Intellectual Property, and Translational Medicine

By Ajanta Pharma Limited
In yet another landmark victory to the Indian Patent Scenario, Ajanta Pharma Limited,emerged successful in revoking two composition patents of Allergan Inc.

By Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has announced its results today where it continued its growth journey during the quarter ended June 30th 2013 with yet another satisfactory performance.

By Zero Corporation
High Impact CRM transforms your business strategically - PRISMS CRM help the medical representatives with Managing Territories, Managing opportunities and tracking competitors Collect Prescription Habit information, Sample & Resource Management

By American Conference Institute
New York The American Conference Institute, organizers of the 18th Annual Drug and Medical Device Litigation Conference taking place December 9 – 11, 2013 at the Marriott Marquis in New York, today announced key highlights from this year’s...

By Visiongain
Visiongain describes the 2012 merger of Actavis and Watson as the key recent development in the world generic drugs industry. The enlarged Actavis has also acquired Warner Chilcott, cementing its place alongside the generics market leader.

By Global Media Strategies
Global Media Strategies Partnering with BioPharma Research Council for 2nd Annual Triangle Biotech Research Symposium

By Visiongain
Visiongain forecasts stronger growth for these market leaders between 2013 and 2023, with revenue growing at a higher rate than for the contract manufacturing market as a whole.

By Carl Nagaitis, Bryher Business Partnership Ltd
Swedish Life Science Company Can Help With Projects That Others Cannot Handle, Says ModePharma Founder And Director Oliver Gupta

By Proove Biosciences
Five New Doctors Begin Administering Proove Genetic Tests in Central and Southern Florida

By Cambridge Healthtech Institute
The 2013 Next Generation Dx Summit to bring together all of the major players in the evolving areas of diagnostics.

By Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has announced its results today for the quarter and year ended March 31st 2013 with yet another sound performance.

By Carl Nagaitis, Bryher Business Partnership
Former AZ Sites In Sweden Are Now Booming Science Parks According to Businesswoman Lucy Robertshaw

By Visiongain
A new report by visiongain predicts that world in vitro diagnostic market revenues overall will reach $81.0bn in 2017.

By Verizon
BASKING RIDGE N.J. – Galderma, a leading global pharmaceutical company focused on dermatology, wanted a cost-efficient means of increasing the capacity of its IT global network infrastructure to support its increasingly data-intensive workload.

By The Scott Partnership
(Santa Barbara, CA) Wyatt Technology announces the immediate availability of the Optilab UT-rEX (UHPLC refractometer with EXtended range), the first RI detector specifically designed for use with UHPLC systems using columns packed with small beads.

By Carl Nagaitis, Bryher Business Partnership
British businesswoman Lucy Robertshaw is spearheading a major new expansion programme by a Scandinavian pharmaceutical manufacturer which aims to attract new business from the UK’s growing Life Science sector.

By Bharat Book Bureau Pleased to announce a new report on "In-Vitro Diagnostics Market Analysis to 2017" which gives the business dynamics of major players in the In-Vitro Diagnostics market..

By Oviya MedSafe Pvt Ltd
KTVR Vijaydeepa Group and Ma Foi Group have come together to launch a new company titled Oviya MedSafe Private Limited, to offer Pharmacovigilance Consulting and Outsourced Drug Safety Support Services to global pharmaceutical companies.

Medtech wire - February 28,2013 eReports: Global Infusion Pumps market is expected to grow at 7% over the next 5 years.According to a newly released reports available at

Medtech wire - February 27,2013 - Injectable Drugs market in the US is expected to grow at 6% over the next 5 years. According to a newly released reports available at

By Bharat Book Bureau Pleased to announce a new report on "2013 Iraq Health Care Sector Outlook" is the single, most comprehensive, insightful and accurate source of reference on the health care industry in Iraq.

By Bryher Business Partnership
APL Plans Expansion After Identifying The UK As One Of Europe's Most Vibrant Markets

By Global Markets Direct
This report provides an overview of the risk factors and global trends of HIV in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging markets—Brazil, India, and China.

Page updated every 10 minutes

  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
Click to Share